Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line

Pathology and Oncology Research

Volumn 16, Issue 2, 2010, Pages 285-293

  Schunemann, Daniel Pretto ^a   Grivicich, Ivana ^a   Regner, Andréa ^a   Leal, Lisiane Freitas ^a   De Araújo, Daniela Romani ^a   Jotz, Geraldo Pereira ^a   Fedrigo, Carlos Alexandre ^a   Simon, Daniel ^a   Da Rocha, Adriana Brondani ^a  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Cell proliferation; EGFR; Glioblastoma multiforme; Glutamate; Phospho Akt

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GLUTAMATE RECEPTOR; GLUTAMIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRYPAN BLUE;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; GLIOBLASTOMA; GLUTAMIC ACID; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, AMPA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77955709724     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9223-4     Document Type: Article

References (66)

1. Gupta T, Sarin R (2002) Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol 3:557-564
2. Nieder C, Astner ST, Mehta MP et al. (2008) Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol 31:300-305
3. Hadziahmetovic M, Lo SS, Clarke JW et al. (2008) Palliative treatment of poor prognosis patients with malignant gliomas. Expert Rev Anticancer Ther 8:125-132
4. Behin A, Hoang-Xuan K, Carpentier AF et al. (2003) Primary brain tumours in adults. Lancet 361:323-331
5. Gunther W, Skaftnesmo KO, Arnold H et al. (2003) Molecular approaches to brain tumour invasion. Acta Neurochir (Wien) 145:1029-1036
6. Hoi Sang U, Espiritu OD, Kelley PY et al. (1995) The role of the epidermal growth factor receptor in human gliomas: I. The control of cell growth. J Neurosurg 82:841-846
7. Chakravarti A, Chakladar A, Delaney MA et al. (2002) The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res 62:4307-4315
8. Krishnan S, Rao RD, James CD et al. (2003) Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas. Front Biosci 8:e1-13
9. Shinojima N, Tada K, Shiraishi S et al. (2003) Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 63:6962-6970
10. Aldape KD, Ballman K, Furth A et al. (2004) Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol 63:700-707
11. Lammering G, Valerie K, Lin PS et al. (2004) Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance. Radiother Oncol 72:267-273
12. Ohgaki H, Dessen P, Jourde B et al. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892-6899
13. Korshunov A, Sycheva R, Golanov A (2005) The prognostic relevance of molecular alterations in glioblastomas for patients age
14. Mellinghoff IK, Wang MY, Vivanco I et al. (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353:2012-2024
15. Arslantas A, Artan S, Oner U et al. (2007) Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas. Pathol Oncol Res 13:39-46
16. Brandt B, Meyer-Staeckling S, Schmidt H et al. (2006) Mechanisms of EGFR gene transcription modulation: relationship to cancer risk and therapy response. Clin Cancer Res 12:7252-7260
17. Sibilia M, Kroismayr R, Lichtenberger BM et al. (2007) The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 75:770-787
18. Choe G, Horvath S, Cloughesy TF et al. (2003) Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63:2742-2746
19. Ghosh MK, Sharma P, Harbor PC et al. (2005) PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells. Oncogene 24:7290-7300
20. Labrakakis C, Patt S, Hartmann J et al. (1998) Glutamate receptor activation can trigger electrical activity in human glioma cells. Eur J NeuroSci 10:2153-2162
21. Sontheimer H (2008) A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 105:287-295
22. Mahé C, Bernhard M, Bobirnac I et al. (2004) Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. Br J Pharmacol 143:404-410
23. Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383-4391
24. Rzeski W, Turski L, Ikonomidou C (2001) Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 98:6372-6377
25. Ishiuchi S, Tsuzuki K, Yoshida Yet al. (2002) Blockage of Ca(2+)- permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971-978
26. D'Onofrio M, Arcella A, Bruno V et al. (2003) Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. J Neurochem 84:1288-1295
27. Aronica E, Gorter JA, Ijlst-Keizers H et al. (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J NeuroSci 17:2106-2118
28. Arcella A, Carpinelli G, Battaglia G et al. (2005) Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro-oncol 7:236-245
29. Takano T, Lin JH, Arcuino G et al. (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015
30. Lyons SA, Chung WJ, Weaver AK et al. (2007) Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67:9463-9471
31. Ishiuchi S, Yoshida Y, Sugawara K et al. (2007) Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27:7987-8001
32. Dziedzic B, Prevot V, Lomniczi A et al. (2003) Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain. J Neurosci 23:915-926
33. Yoshida Y, Tsuzuki K, Ishiuchi S et al. (2006) Serum-dependence of AMPA receptor-mediated proliferation in glioma cells. Pathol Int 56:262-271
34. Sigalas E, Regan JD, Kramer PR et al. (2004) Survival of human periodontal ligament cells in media proposed for transport of avulsed teeth. Dent Traumatol 20:21-28
35. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
36. Schmidt M, Bachhuber A, Victor A et al. (2003) p53 expression and resistance against paclitaxel in patients with metastatic breast cancer. J Cancer Res Clin Oncol 129:295-302
37. Knobbe CB, Reifenberger G (2003) Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol- 3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507-518
38. Regner A, Schunemann DP, Grivicich I et al. (2005) Effects of toxic doses of glutamate on Cu-Zn and Mn/superoxide dismutases activities in human glioma cell lines. J Neurooncol 71:9-17
39. Campbell GL, Bartel R, Freidman HS et al. (1985) Effect of glutamate analogues on brain tumor cell lines. J Neurochem 45:1186-1192
40. Chen CJ, Liao SL, Kuo JS (2000) Gliotoxic action of glutamate on cultured astrocytes. J Neurochem 75:1557-1565
41. Matute C, Alberdi E, Ibarretxe G et al. (2002) Excitotoxicity in glial cells. Eur J Pharmacol 447:239-246
42. Skog J, Würdinger T, van Rijn S et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476
43. Peavy RD, Chang MS, Sanders-Bush E et al. (2001) Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J Neurosci 21:9619-9628
44. Taylor S, Srinivasan B, Wordinger RJ et al. (2003) Glutamate stimulates neurotrophin expression in cultured Muller cells. Brain Res Mol Brain Res 111:189-197
45. Prenzel N, Fischer OM, Streit S et al. (2001) The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8:11-31
46. Yarden Y, Sliwkowski M (2001) Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2:27-137
47. Holbro T, Civenni G, Hynes NE (2003) The ErbB receptors and their role in cancer progression. Exp Cell Res 284:99-110
48. Chung WJ, Lyons SA, Nelson GM et al. (2005) Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25:7101-7110
49. de Groot JF, Liu TJ, Fuller G et al. (2005) The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res 65:1934-1940
50. Voelzke WR, Petty WJ, Lesser GJ (2008) Targeting the epidermal growth factor receptor in high-grade astrocytomas. Curr Treat Options in Oncol 9:23-31
51. Shawver LK, Slamon D, Ullrich A (2002) Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1:117-123
52. Viana-Pereira M, Lopes JM, Little S et al. (2008) Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas. Anticancer Res 28:913-920
53. Lokker NA, Sullivan CM, Hollenbach SJ et al. (2002) Plateletderived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62:3729-3735
54. Servidei T, Riccardi A, Sanguinetti M et al. (2006) Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. J Cell Physiol 208:220-228
55. Wang MY, Lu KV, Zhu S et al. (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTENintact glioblastoma cells. Cancer Res 66:7864-7869
56. Mendelsohn J, Baselga J (2003) Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21:2787-2799
57. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
58. Parsa AT, Holland EC (2004) Cooperative translational control of gene expression by Ras and Akt in cancer. Trends Mol Med 10:607-613
59. Holland EC, Celestino J, Dai C et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastomas formation in mice. Nat Genet 25:55-57
60. Sonoda Y, Ozawa T, Aldape KD et al. (2001) Akt pathway activation converts anaplastic astrocytoma to glioblastomas multiforme in a human astrocyte model of glioma. Cancer Res 61:6674-6678
61. Sanson M, Thillet J, Hoang-Xuan K (2004) Molecular changes in gliomas. Curr Opin Oncol 16:607-613
62. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2:489-501
63. Santini MT, Rainaldi G (1999) Three-dimensional spheroid model in tumor biology. Pathobiology 67:148-157
64. Bates RC, Edwards NS, Yates JD (2000) Spheroids and cell survival. Crit Rev Oncol Hematol 36:61-74
65. Ye ZC, Rothstein JD, Sontheimer H (1999) Compromised glutamate transport in human glioma cells: reductionmislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 19:10767-10777
66. Roslin M, Henriksson R, Bergstrom P et al. (2003) Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol 61:151-16041. Matute C, Alberdi E, Ibarretxe G et al. (2002) Excitotoxicity in glial cells. Eur J Pharmacol 447:239-246